Back to Search
Start Over
Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson's disease
- Source :
- Molecular Pain
- Publication Year :
- 2017
-
Abstract
- Background Although pain is one of the most distressing non-motor symptoms among patients with Parkinson's disease, the underlying mechanisms of pain in Parkinson's disease remain elusive. The aim of the present study was to investigate the role of serotonin (5-hydroxytryptamine) in the rostral ventromedial medulla (RVM) and spinal cord in pain sensory abnormalities in a 6-hydroxydopamine-treated rat model of Parkinson's disease. Methods The rotarod test was used to evaluate motor function. The radiant heat test and von Frey test were conducted to evaluate thermal and mechanical pain thresholds, respectively. Immunofluorescence was used to examine 5-hydroxytryptamine neurons and fibers in the rostral ventromedial medulla and spinal cord. High-performance liquid chromatography was used to determine 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels. Results The duration of running time on the rotarod test was significantly reduced in 6-hydroxydopamine-treated rats. Nociceptive thresholds of both mechanical and heat pain were reduced compared to sham-treated rats. In addition to the degeneration of cell bodies and fibers in the substantia nigra pars compacta, the number of rostral ventromedial medulla 5-hydroxytryptamine neurons and 5-hydroxytryptamine fibers in the spinal dorsal horn was dramatically decreased. 5-Hydroxytryptamine concentrations in both the rostral ventromedial medulla and spinal cord were reduced. Furthermore, the administration of citalopram significantly attenuated pain hypersensitivity. Interestingly, Intra-rostral ventromedial medulla (intra-RVM) microinjection of 5,7-dihydroxytryptamine partially reversed pain hypersensitivity of 6-hydroxydopamine-treated rats. Conclusions These results suggest that the decreased 5-hydroxytryptamine contents in the rostral ventromedial medulla and spinal dorsal horn may be involved in hyperalgesia in the 6-hydroxydopamine-induced rat model of Parkinson's disease.
- Subjects :
- 0301 basic medicine
Male
Indoles
Receptors, Opioid, mu
Rats, Sprague-Dawley
0302 clinical medicine
Serotonin Agents
Medicine
pain
gamma-Aminobutyric Acid
Medulla Oblongata
Parkinson Disease
Nociception
medicine.anatomical_structure
Hyperalgesia
Molecular Medicine
medicine.symptom
rostral ventromedial medulla
Selective Serotonin Reuptake Inhibitors
Signal Transduction
Research Article
medicine.medical_specialty
Serotonin
Tyrosine 3-Monooxygenase
5,7-Dihydroxytryptamine
Substantia nigra
5-hydroxytryptamine
03 medical and health sciences
Cellular and Molecular Neuroscience
Internal medicine
Nociception assay
Animals
Oxidopamine
Medulla
business.industry
Pars compacta
spinal cord
Spinal cord
Rats
Disease Models, Animal
030104 developmental biology
Anesthesiology and Pain Medicine
Endocrinology
nervous system
Sympatholytics
Parkinson’s disease
Rostral ventromedial medulla
business
Neuroscience
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 17448069
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Molecular pain
- Accession number :
- edsair.doi.dedup.....70c176130431df7a8a4f5f9f31132512